NCT07024394 2025-06-17Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.Phase 1/2 Not yet recruiting65 enrolled